マレーシア - 英語 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -

マレーシア - 英語 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -

マレーシア - 英語 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -

イスラエル - 英語 - Ministry of Health

novartis israel ltd - indacaterol as maleate - inhalation powder hard capsules - indacaterol as maleate 150 mcg - indacaterol - maintenance of bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease (copd).

イスラエル - 英語 - Ministry of Health

novartis israel ltd - glycopyrronium as bromide; indacaterol as maleate - inhalation powder hard capsules - indacaterol as maleate 110 mcg; glycopyrronium as bromide 50 mcg - indacaterol - ultibro breezhaler is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

欧州連合 - 英語 - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol acetate, mometasone furoate - asthma - drugs for obstructive airway diseases, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

欧州連合 - 英語 - EMA (European Medicines Agency)

novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - asthma - drugs for obstructive airway diseases, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.

欧州連合 - 英語 - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol, mometasone furoate - asthma - drugs for obstructive airway diseases, - bemrist breezhaler is indicated as a maintenance   treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

欧州連合 - 英語 - EMA (European Medicines Agency)

novartis europharm limited - indacaterol maleate - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - hirobriz breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease.

欧州連合 - 英語 - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol maleate - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - oslif breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease.